1. Long-term outcome of invasive pure micropapillary breast cancer compared with invasive mixed micropapillary and invasive ductal breast cancer: a matched retrospective study
- Author
-
Magnoni, F, Bianchi, B, Pagan, E, Corso, G, Sala, I, Bagnardi, V, Claudia, S, Brancaccio, R, Bottazzoli, E, Boato, A, Munzone, E, Dellapasqua, S, Fusco, N, Viviana, G, Veronesi, P, Magnoni, Francesca, Bianchi, Beatrice, Pagan, Eleonora, Corso, Giovanni, Sala, Isabella, Bagnardi, Vincenzo, Claudia, Sangalli, Brancaccio, Roberta, Bottazzoli, Elisa, Boato, Antony, Munzone, Elisabetta, Dellapasqua, Silvia, Fusco, Nicola, Viviana, Galimberti, Veronesi, Paolo, Magnoni, F, Bianchi, B, Pagan, E, Corso, G, Sala, I, Bagnardi, V, Claudia, S, Brancaccio, R, Bottazzoli, E, Boato, A, Munzone, E, Dellapasqua, S, Fusco, N, Viviana, G, Veronesi, P, Magnoni, Francesca, Bianchi, Beatrice, Pagan, Eleonora, Corso, Giovanni, Sala, Isabella, Bagnardi, Vincenzo, Claudia, Sangalli, Brancaccio, Roberta, Bottazzoli, Elisa, Boato, Antony, Munzone, Elisabetta, Dellapasqua, Silvia, Fusco, Nicola, Viviana, Galimberti, and Veronesi, Paolo
- Abstract
Purpose: Data on the prognostic impact of the micropapillary component in breast cancer are limited. The purpose of this study was to investigate the clinicopathological characteristics and long-term outcomes of pure and mixed invasive micropapillary breast cancer (IMPC) patients compared to invasive ductal cancer (IDC) patients. Methods: This retrospective study analysed all IMPC and IDC patients treated at the European Institute of Oncology (IEO) between 1997 and 2019. The overall cohort of IMPC patients was divided in two groups, pure and mixed IMPC. Each patient with mixed or pure IMPC was matched with one patient with IDC, based on year of surgery, age, pT, pN, and molecular subtype. Results: A total of 30,115 IDC, 120 pure IMPC and 150 mixed IMPC patients were considered eligible. Compared to IDC, pure and mixed IMPC patients presented a higher rate of locally advanced disease (pT2-T3, pN2-N3), vascular invasion, and Luminal B subtype. After matching, pure and mixed IMPC showed a significant higher rate of vascular invasion compared to IDC patients (p < 0.001). Invasive disease-free survival was better in IDC compared to pure IMPC patients (p = 0.11). Long-term overall survival was significantly worse in pure IMPC group compared to IDC group (p = 0.004), being instead similar between mixed IMPC vs matched IDC (p = 0.07). Conclusion: These real-world data reported the worse prognosis of pure IMPC compared to IDC, highlighting the peculiar prognostic value of the micropapillary subtype itself in the decision-making process of IMPC management. An accurate pre-surgical diagnostic evaluation and a multidisciplinary approach are pivotal to best personalize its treatment.
- Published
- 2024